Implementation of high resolution single nucleotide polymorphism array analysis as a clinical test for patients with hematologic malignancies.
- Authors
- Dougherty, Margaret J; Wilmoth, Donna M; Tooke, Laura S; Shaikh, Tamim H; Gai, Xiaowu; Hakonarson, Hakon; Biegel, Jaclyn A
- Year
- 2011
- Journal
- Cancer genetics
- PMID
- 21356189
- DOI
- 10.1016/j.cancergencyto.2010.10.007
Single nucleotide polymorphism-based oligonucleotide arrays have been used as a research tool to detect genomic copy number changes and allelic imbalance in a variety of hematologic malignancies and solid tumors. The high resolution, genome-wide coverage, minimal DNA requirements, and relatively short turnaround time are advantageous for use in a clinical setting. We validated the Illumina HumanHap550 BeadChip array for clinical use by analyzing 127 pediatric leukemia and lymphoma samples that had previously been characterized by means of standard cytogenetic analysis and fluorescence in situ hybridization. A higher resolution Illumina HumanHap610 BeadChip array was ultimately used for clinical testing. To date, 180 samples from children with a suspected or confirmed hematologic malignancy have been analyzed. Of the 180 clinical samples, 130 (72%) bone marrow or lymphoma specimens had aberrations revealed by the array that were not seen in the karyotypes. These typically included deletions in genes associated with B- or T-cell malignancies, such as CDKN2A/B, PAX5, and IKZF1. There were also 75 regions of copy number neutral loss of heterozygosity (>5 Mb threshold) detected in 49 samples in this cohort, which could be categorized as constitutional or acquired abnormalities. On the basis of our experience in the last 2 years, we suggest that single nucleotide polymorphism arrays are a valuable addition to, but not a replacement for, standard cytogenetic approaches for hematologic malignancies.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Detectable clonal mosaicism from birth to old age and its relationship to cancer. | 2012 | 22561516 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Approach to the diagnosis of aplastic anemia. | DeZern AE et al. | — | 2021 | → |
| Genetic Predisposition to Myelodysplastic Syndrome in Clinical Practice. | Schratz KE et al. | — | 2020 | → |
| Clinical use of SNP-microarrays for the detection of genome-wide changes in haematological malignancies. | Berry NK et al. | — | 2019 | → |
| Improved cytogenetic characterization and risk stratification of pediatric acute lymphoblastic leukemia using single nucleotide polymorphism array analysis: A single center experience of 296 cases. | Olsson L et al. | — | 2018 | → |
| Prenatal diagnosis of sex chromosomal inversion, translocation and deletion. | Zhang L et al. | — | 2018 | → |
| Copy number alterations determined by single nucleotide polymorphism array testing in the clinical laboratory are indicative of gene fusions in pediatric cancer patients. | Busse TM et al. | — | 2017 | → |
| Detection of complex genomic signatures associated with risk in plasma cell disorders. | Berry NK et al. | — | 2017 | → |
| Patterns and frequencies of acquired and constitutional uniparental isodisomies in pediatric and adult B-cell precursor acute lymphoblastic leukemia. | Lundin KB et al. | — | 2016 | → |
| Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray study. | Baughn LB et al. | — | 2015 | → |
| Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing? | Peterson JF et al. | — | 2015 | → |
| SNPs Array Karyotyping in Non-Hodgkin Lymphoma. | Etebari M et al. | — | 2015 | → |
| Acquired isochromosome 12p, somatic TP53 and PTEN mutations, and a germline ATM variant in an adolescent male with concurrent acute megakaryoblastic leukemia and mediastinal germ cell tumor. | Oshrine BR et al. | — | 2014 | → |
| Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphoma. | Pei J et al. | — | 2014 | → |
| Diagnostic application of high resolution single nucleotide polymorphism array analysis for children with brain tumors. | Roth JJ et al. | — | 2014 | → |
| Molecular genetic methods in the diagnosis of myelodysplastic syndromes. A review. | Lukackova R et al. | — | 2014 | → |
| Unsuccessful diagnostic cytogenetic analysis is a poor prognostic feature in acute myeloid leukaemia. | Medeiros BC et al. | — | 2014 | → |
| Different characteristics identified by single nucleotide polymorphism array analysis in leukemia suggest the need for different application strategies depending on disease category. | Huh J et al. | — | 2013 | → |
| Single nucleotide polymorphism array-based karyotyping in acute myeloid leukemia or myelodysplastic syndrome with trisomy 8 as the sole chromosomal abnormality. | Hahm C et al. | — | 2013 | → |
| The advantage of using SNP array in clinical testing for hematological malignancies--a comparative study of three genetic testing methods. | Xu X et al. | — | 2013 | → |
| Use of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemia. | Iacobucci I et al. | — | 2013 | → |
| Clinical utilization of high-resolution single nucleotide polymorphism based oligonucleotide arrays in diagnostic studies of pediatric patients with solid tumors. | Dougherty MJ et al. | — | 2012 | → |
| Detectable clonal mosaicism from birth to old age and its relationship to cancer. | Laurie CC et al. | — | 2012 | → |
| Genome-wide arrays in routine diagnostics of hematological malignancies. | Simons A et al. | — | 2012 | → |
| The use of new technologies in the detection of balanced translocations in hematologic disorders. | Shaffer LG et al. | — | 2012 | → |
| Clinical laboratory implementation of cytogenomic microarrays. | South ST et al. | — | 2011 | → |
| Microarray-based genomic profiling as a diagnostic tool in acute lymphoblastic leukemia. | Simons A et al. | — | 2011 | → |